on its pending US ~$40.0 billion SPAC Merger with

on its pending $19.7 billion sale to

the Board of Directors of

on its pending $29 billion acquisition of

on its pending ~$30 billion combination of

GE Capital Aviation Services with

on its $7.2 billion acquisition of

~$403 Million
Convertible Notes Offering

on its pending $39
billion acquisition
of

on its pending $11.6 billion acquisition of

$414 Million

CAPS ™ Initial Public Offering

$704 Million

Initial Public Offering

Advising Clarivate on its pending
$6.8 billion combination
with CPA Global

on its pending $11.9 billion sale to

on its pending ~ $7.5 billion merger
with

$14.4 Billion

Follow-on Offering

sale of ~22.4% stake in

$3.5 Billion
Follow-on Offering &
5.0% Mandatory Convertible
Preferred

$1.4 Billion

Initial Public Offering

Advising DuPont on the pending merger  of its Nutrition & Biosciences business with IFF  via a Reverse Morris Trust

on its approximately $60 billion sale to

on its pre-packaged chapter 11 restructuring of $9.3bn of debt and contingent liabilities and sales of the Lummus segment

Ongoing

on its activism defense against

& on its $93 billion acquisition of

on its chapter 11 restructuring of $2.8 billion of debt

Ongoing

on its activism defense against